A population-based cohort study of HRT use and breast cancer in southern Sweden
2001

HRT Use and Breast Cancer Risk in Southern Sweden

Sample size: 29508 publication Evidence: moderate

Author Information

Author(s): Olsson H, Bladström A, Ingvar C, Möller T R

Primary Institution: Department of Oncology, University Hospital, Lund

Hypothesis

Does hormone replacement therapy (HRT) increase the risk of breast cancer in women?

Conclusion

The study found a significant excess of breast cancer among women who used HRT compared to those who never used it.

Supporting Evidence

  • The study included 29,508 women and followed them for breast cancer incidence.
  • There were 226,611 person-years of observation.
  • A total of 1,145 malignant tumors were recorded during the study.
  • The study found a significant excess of breast cancer among HRT users.
  • Breast cancer risk increased with longer duration of HRT use.

Takeaway

This study looked at a lot of women to see if using hormone therapy makes them more likely to get breast cancer, and it found that it does.

Methodology

The study followed a cohort of women and analyzed breast cancer incidence in relation to HRT use over time.

Potential Biases

Potential biases related to self-reported HRT use and family history.

Limitations

The study may not account for all confounding factors related to breast cancer risk.

Participant Demographics

Women aged 25–65 from southern Sweden.

Statistical Information

Confidence Interval

95% CI 1.02–1.23

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1054/bjoc.2001.1899

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication